desoxycorticosterone acetate has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, N; Gandhi, H; Naik, P; Yadav, M | 1 |
1 other study(ies) available for desoxycorticosterone acetate and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Chromones; Desoxycorticosterone Acetate; Endothelium, Vascular; Hypertension; Losartan; Male; Mineralocorticoids; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Prazosin; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Angiotensin; Signal Transduction; Vasoconstriction | 2016 |